TWO SIGMA INVESTMENTS, LP

Position in OVID — Ovid Therapeutics Inc.

CIK 1179392 NEW YORK, NY

Position in OVID

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,239,096

-$551,153 QoQ

Shares Held

832,378

-33.8% QoQ

Ownership

0.426%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#27

of 131 holders

Holding Since

Mar 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

TWO SIGMA INVESTMENTS, LP holds $7,273,657,992 across 342 Biotechnology names. OVID ranks #152 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	1,875,937	$564,713,315
2	MRNA	Moderna, Inc.	7,193,530	$503,762,905
3	IONS	Ionis Pharmaceuticals Inc	6,252,342	$495,748,197
4	REGN	Regeneron Pharmaceuticals, Inc.	656,124	$409,119,558
5	BBIO	BridgeBio Pharma, Inc.	4,722,185	$351,708,338
6	EXEL	Exelixis, Inc.	4,209,861	$229,058,537
7	INCY	Incyte Corp	2,003,559	$227,123,448
8	ARGX	Argenx SE	185,638	$172,229,367

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,239,096	832,378	-33.8%	Shares	Sole	2026-08-14
2026-03-31	$2,790,249	1,256,869	+109.9%	Shares	Sole	2026-05-15
2025-12-31	$976,156	598,869	+75.6%	Shares	Sole	2026-02-17
2025-09-30	$443,474	341,134	+2601.4%	Shares	Sole	2025-11-14
2024-06-30	$9,710	12,628	-68.9%	Shares	Sole	2024-08-14
2024-03-31	$124,040	40,669	-85.9%	Shares	Sole	2024-05-15
2021-06-30	$1,129,129	288,780	-16.5%	Shares	Sole	2021-08-16
2020-12-31	$798,580	345,706	+7.9%	Shares	Sole	2021-02-16
2020-09-30	$1,838,321	320,265	+932.7%	Shares	Sole	2020-11-16
2020-03-31	$92,415	31,012	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.